Beta Bionics, Inc. Common Stock BBNX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| I Let | $10.09M-32.0% | $14.84M+4.7% | $14.18M+5.7% | $13.41M+39.3% | $9.63M-28.7% | |
| Single Use Products | $10.24M+36.6% | $7.5M+9.6% | $6.84M+30.8% | $5.23M+24.6% | $4.2M-5.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Beta Bionics, Inc. Common Stock break its business down?
- Beta Bionics, Inc. Common Stock (BBNX) reports revenue by product across 2 parts — I Let and Single Use Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Beta Bionics, Inc. Common Stock's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Beta Bionics, Inc. Common Stock's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
